Adenosine
Product Images NDC 17478-953

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 17478-953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ade0g 0004 01

Chemical structure of Adenosine showing its molecular formula C10H13N5O4. The image depicts the arrangement of atoms in the molecule including a purine base attached to a ribose sugar.*

FDA Label Image

Ade0g 0004 02

The label for Adenosine Injection, USP by Akorn displays a 2 mL single-dose vial with 6 mg per 2 mL (3 mg/mL) concentration. It specifies use for rapid bolus intravenous administration. Storage instructions note 20 to 25°C and protection from light, with no refrigeration. The label includes the NDC 17478-953-02 and barcode.*

FDA Label Image

Ade0g 0004 03

Adenosine Injection, USP label by Akorn for 6 mg/2 mL (3 mg/mL) solution in 10 vials of 2 mL each. The label highlights rapid bolus intravenous use, sterile and nonpyrogenic status, and Rx-only designation. Storage and usage cautions, ingredient composition, and the Novaplus logo are also visible on the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.